Objective:

To investigate factors associated with recent STBBI testing among clients of harm reduction sites in British Columbia, emphasizing the public health implications of these findings.

Key Findings:

• High prevalence of STBBIs among people who use substances (PWUS) in BC, with significant barriers to testing, including specific statistics on prevalence rates.
• Community-based, low-barrier approaches, such as point-of-care testing at harm reduction sites, can increase testing uptake, supported by data from pilot initiatives.
• Stigma, discrimination, and social determinants of health significantly hinder access to STBBI testing for PWUS, highlighting the need for targeted interventions.

Interpretation:

Addressing barriers to STBBI testing through harm reduction services is crucial for early detection and treatment, ultimately reducing STBBI transmission among PWUS, particularly through community engagement.

Limitations:

• The study relies on self-reported data, which may be subject to bias.
• Findings may not be generalizable beyond the specific harm reduction sites surveyed.
• Potential biases in convenience sampling may affect the representativeness of the sample.

Conclusion:

Enhancing STBBI testing access in harm reduction settings is vital for improving health outcomes for PWUS and reducing the burden of STBBIs, with an emphasis on community involvement.

Sources:

• BC Harm Reduction Client Survey